Details of the Drug

General Information of Drug (ID: DM26BMD)

• Drug Name: Anti-CD45 mAb 131I-BC8

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 2	[1]

• Cross-matching ID: TTD ID: D0N4NH

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)